The only tangentially relevant data comes from amphetamine studies where BPC-157 counteracted stereotypy and prevented behavioral sensitization, but amphetamine-induced stereotypy models psychosis and stimulant abuse, not ADHD symptoms
Some people are going to call me nuts but I choose this over Hospira
Compound GHK-Cu (Copper Tripeptide-1) CAS Number 89030-95-5 Sequence Gly-His-Lys (copper-bound) Molecular weight ~403.9 g/mol Purity 99% (HPLC verified) Form Lyophilised powder Contents 50mg or 100mg per vial Packaging Sealed sterile research vial Storage (lyophilised) 28C, protect from light & moisture Storage (reconstituted) 28C, use within 28 days Reconstitution Bacteriostatic water (recommended)
Each modifier applies to one specific payer-scenario combination, and using the wrong modifier in the wrong context is as damaging as using the wrong CPT code
Lay out a clean surface with the IGF-1 LR3 vial, BAC water, alcohol swabs, and a sterile syringe
Although BPC-157 has been proven safe and well-tolerated in clinical trials, there are potential risks such as allergic reactions, interactions with other medications, and unknown long-term effects